Bayer sells MR endorectal coil product line to DxTx Medical
advertisement
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

New progress on manganese-based MR contrast agent Enhances tumor similarly to gadolinium but clears better

New study calls for prebiopsy MR scans in prostate cancer assessment Better able to detect cancers that likely require treatment

NIH researchers uncover potential new indication of severe MS Based on dark-rimmed marks on patient brains

Trendy magnetic eyelashes are the latest potential hazard in the MR suite Can cause artifacts, detach during procedures

MR brain scans reveal differences in US personnel formerly stationed in Cuba Incurred from intensely loud noises in homes and hotel rooms

Study advises personalized breast cancer screenings for cancer survivors May benefit from MR alone, rather than MR and mammography

Knitting raises thousands for Scottish MR scanner fundraising campaign Improving access to care in remote Shetland Islands

CT and MR waiting times costing Canadians over $3 billion Need $4.4 billion to update imaging stock, says report

MR and ultrasound biopsies combined can detect prostate cancers, says study Detect up to 33 percent more tumors together

Demand on the rise for MR-guided radiotherapy, says new report Compound annual growth rate of 20 percent through 2028

DxTx Medical has acquired
Bayer's MR endorectal coil
product line.

Bayer sells MR endorectal coil product line to DxTx Medical

por John R. Fischer , Staff Reporter
Radiology accessories manufacturer DxTx Medical has acquired the rights to Bayer’s MR endorectal coil product line.

The purchase of the eCoil line of products provides the Pennsylvania-based company with access to high-resolution imaging technologies for examination of prostate, colorectal, cervix, and surrounding pelvis anatomies.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“DxTx Medical is committed to providing medical professionals with technology that enhances their ability to provide the best treatment options for the patients they support,” Xueli Wang, president and CEO of DxTx Medical, told HCB News. “The eCoil MR Endorectal coil is well established in high-resolution imaging, and product support and warranty protection will continue as a mainstay for existing as well as new customers.”

The MR Endorectal coil provides a high signal-to-noise ratio (SNR) that equips 1.5T and 3.0T MR scanners with multi-parametric and spectroscopy imaging capabilities. Its influence on the small field of vision and high spatial resolution images improves sensitivity and specificity in diagnosis and helps in treatment planning.

Transfer of the line will take place in a period of phases while DxTx Medical sets up its licensing and distribution infrastructure outside the U.S. The first, which went into effect on August 1, will oversee DxTx Medical manufacturing and distributing products to U.S. providers.

Bayer will continue to support product sales for non-U.S. clientele, marketing under the Medrad eCoil brand, until August 31, at which point DxTx Medical will assume responsibility for product manufacturing and distribution globally — with the exception of Italy, where the transition is expected to take place on September 30.

"The timing to sell the product line fits with our objective to focus investment in growing our core products in CT and MR injectors, contrast agents and informatics," Dennis Durmis, SVP - head of region Americas - radiology at Bayer told HCB News. "Our decision will allow the opportunity for DxTx to innovate and invest in the ecoil segment to benefit our customers and patients."

News of the sale follows the closing of Bayer’s announcement in January to close its Robinson Campus operations in Pittsburgh in an effort to consolidate the company. Its radiology business at its O’Hara Township, Saxonburg and Indianola, Pittsburgh locations, it said would not be affected by the shutdown. It also previously sold its multi-vendor service operations in 2017 to Capital Partners and North Park Capital Partners.

DxTx Medical plans to introduce upgraded interface device capabilities to enhance the MR Endorectal coil for new platforms of MR scanners.

Bayer will provide more details on the transition to international customers later this summer.

No financial details of the sale were disclosed.

MRI Homepage


You Must Be Logged In To Post A Comment